Study: NCT05725200

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Alectinib
Description: Dosage form, dosage, frequency and duration are to be implemented by study investigators as described in the current Summary of Product Characteristics (SMPC) and package Insert.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cetuximab
Description: Dosage form, dosage, frequency and duration are to be implemented by study investigators as described in the current SMPC and package Insert.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Crizotinib
Description: Dosage form, dosage, frequency and duration are to be implemented by study investigators as described in the current SMPC and package Insert.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dasatinib
Description: Dosage form, dosage, frequency and duration are to be implemented by study investigators as described in the current SMPC and package Insert.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Everolimus
Description: Dosage form, dosage, frequency and duration are described in the current SMPC and package Insert.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Encorafenib
Description: Dosage form, dosage, frequency and duration are to be implemented by study investigators as described in the current SMPC and package Insert.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Gemcitabine
Description: Dosage form, dosage, frequency and duration are described in the current SMPC and package Insert.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Idelalisib
Description: Dosage form, dosage, frequency and duration are to be implemented by study investigators as described in the current SMPC and package Insert.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Larotrectinib
Description: Dosage form, dosage, frequency and duration are to be implemented by study investigators as described in the current SMPC and package Insert.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Methotrexate
Description: Dosage form, dosage, frequency and duration are to be implemented by study investigators as described in the current SMPC and package Insert.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Palbociclib
Description: Dosage form, dosage, frequency and duration are to be implemented by study investigators as described in the current SMPC and package Insert.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Panobinostat
Description: Dosage form, dosage, frequency and duration are to be implemented by study investigators as described in the current SMPC and package Insert.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pembrolizumab
Description: Dosage form, dosage, frequency and duration are to be implemented by study investigators as described in the current SMPC and package Insert.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Petrozumab
Description: Dosage form, dosage, frequency and duration are to be implemented by study investigators as described in the current SMPC and package Insert.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Trastuzumab
Description: Dosage form, dosage, frequency and duration are to be implemented by study investigators as described in the current SMPC and package Insert.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Talazoparib
Description: Dosage form, dosage, frequency and duration are to be implemented by study investigators as described in the current SMPC and package Insert.